These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16848726)

  • 1. Evaluation of mucin as a release enhancer for rectal delivery of glibenclamide.
    Adikwu MU; Okafor JO
    Curr Drug Deliv; 2006 Jul; 3(3):243-54. PubMed ID: 16848726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of snail mucin motifs as rectal absorption enhancer for insulin in non-diabetic rat models.
    Adikwu MU
    Biol Pharm Bull; 2005 Sep; 28(9):1801-4. PubMed ID: 16141566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether.
    Hosny EA; Al-Shora HI; Elmazar MM
    Biol Pharm Bull; 2001 Nov; 24(11):1294-7. PubMed ID: 11725967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of mucin-gelatin mucoadhesive microspheres for rectal delivery of ceftriaxone sodium.
    Ofokansi KC; Adikwu MU; Okore VC
    Drug Dev Ind Pharm; 2007 Jun; 33(6):691-700. PubMed ID: 17613033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and utility of glibenclamide suppository for hospital use].
    Takahashi Y; Iwata M; Shirotake S; Takayama K; Machida Y; Nagai T
    Yakugaku Zasshi; 1998 Sep; 118(9):401-7. PubMed ID: 9779000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
    Yun M; Choi H; Jung J; Kim C
    Int J Pharm; 1999 Nov; 189(2):137-45. PubMed ID: 10536242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement by adjuvants on the rectal bioavailability of non-absorbable drugs following administration of suppository.
    Nakanishi K; Masada M; Nadai T
    J Pharmacobiodyn; 1990 Dec; 13(12):760-5. PubMed ID: 2098548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
    Onyeji CO; Adebayo AS; Babalola CP
    Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of physical and hypoglycaemic properties of rectal suppositories with chosen insulin.
    Kosior A
    Acta Pol Pharm; 2002; 59(5):353-8. PubMed ID: 12602796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved systemic delivery of insulin by condensed drug loading in a dimpled suppository.
    Matsumoto A; Murakami K; Watanabe C; Murakami M
    Drug Discov Ther; 2017; 11(6):293-299. PubMed ID: 29332886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of optimal in vitro release and permeation testing method for rectal suppositories.
    Srivatsa Palakurthi S; Bharat Charbe N; Recalde Phillips SY; Alge DL; Lu D; Palakurthi S
    Int J Pharm; 2023 Jun; 640():123042. PubMed ID: 37178789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-shell nano-biomaterials for controlled oral delivery and pharmacodynamic activity of glibenclamide.
    Maiti S; Mukherjee S; Datta R
    Int J Biol Macromol; 2014 Sep; 70():20-5. PubMed ID: 24971559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository.
    Nakanishi K; Masukawa T; Masada M; Nadai T
    Biol Pharm Bull; 1994 Nov; 17(11):1496-500. PubMed ID: 7703971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable microspheres based on gelatin-porcine mucin admixtures: in vitro and in vivo delivery studies.
    Ofokansi KC; Okorie O; Adikwu MU
    Biol Pharm Bull; 2009 Oct; 32(10):1754-9. PubMed ID: 19801839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal absorption enhancement of gentamicin in rabbits from hollow type suppositories by sodium salicylate or sodium caprylate.
    Matsumoto Y; Watanabe Y; Tojima T; Murakoshi R; Murakami C; Matsumoto M
    Drug Des Deliv; 1989 May; 4(3):247-56. PubMed ID: 2490276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of availability of allopurinol from pharmaceutical dosage forms I - suppositories.
    Samy EM; Hassan MA; Tous SS; Rhodes CT
    Eur J Pharm Biopharm; 2000 Mar; 49(2):119-27. PubMed ID: 10704894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled drug delivery attributes of co-polymer micelles and xanthan-O-carboxymethyl hydrogel particles.
    Maiti S; Mukherjee S
    Int J Biol Macromol; 2014 Sep; 70():37-43. PubMed ID: 24954271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro properties of ciprofloxacin suppositories formulated with glycerogelatin and theobroma oil bases.
    Ofoefule SI; Nwankwo C; Chukwu A; Orisakwe OE
    Boll Chim Farm; 1998 Oct; 137(9):341-4. PubMed ID: 9859595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.